理想汽車(02015.HK)2月交付8,414輛理想ONE 增長2.65倍
理想汽車(02015.HK)(LI.US)公佈交付數據,2月份共交付8,414輛理想ONE,交付量按年增長265.8%。自上市以來,理想ONE累計交付14.48萬輛。
截至2022年2月28日,理想汽車在全國已有220家零售中心,覆蓋105個城市;售後維修中心及理想汽車授權鈑噴中心279家,覆蓋204個城市。
聯合創始人兼總裁沈亞楠稱,因春節的季節性因素和蘇州疫情的影響,部分零部件供應短缺導致生產受到影響,公司正在採取更多措施,以確保零部件的供應,儘可能地確保生產、縮短用戶提車等待週期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.